News
Events
News
Technology
March 30, 2026
uBriGene and Cellinfinity BIO Partner to Advance In Vivo CAR-T Therapies for Solid Tumors
News
Technology
March 16, 2026
uBriGene Supports FDA IND Clearance of Next-Generation Gene-Edited TIL Therapy GT307 Through Integrated Cell Therapy CDMO Manufacturing
News
Technology
December 16, 2025
uBriGene Launches LVV Turbo™ – Its Next-Generation GMP Lentiviral Vector Manufacturing Platform – and announces a Strategic Partnership with Syenex for integration of its UltraCell™ Technology
News
Technology
December 9, 2025
uBriGene Biosciences and Circurna Announce Strategic Partnership to Accelerate Development and Manufacturing of Circular RNA/LNP Therapeutics
News
Technology
September 17, 2025
uBriGene Unveils V2.0 RNA-LNP iPSC Reprogramming Kit Optimized for PBMCs and Hard-to-Reprogram Cells
News
Technology
June 16, 2025
uBriGene Launches Clinical iPSC Banks to Accelerate Regenerative Medicine and Cell Therapy Development
News
Technology
March 4, 2025
Faster Clinical Translation and Commercialization of Therapies Derived From iPSC Technology
News
Corporate
August 7, 2024
uBriGene Biosciences Congratulates Strategic Partner InnoVec Biotherapeutics on FDA Clearance of IND for IVB103, An AAV-based Gene Therapy
News
Technology
April 24, 2024
uBriGene's Educational Webinar Series on ATMPs Development and Manufacturing
News
Technology
March 13, 2024
New Service Launch - Cell Therapy Potency Analytical Development and GMP Testing
News
Technology
February 1, 2024
Top 3 success factors for cell therapy potency assays
News
Corporate
July 31, 2023
uBriGene (Boston) Biosciences completed the transaction with Mustang Bio, Inc. (Nasdaq: MBIO)
News
Corporate
May 18, 2023
Cell and Gene Therapy CDMO Targets North American Growth with Major US Acquisition
News
Corporate
April 20, 2023
uBriGene Biosciences Inc. closes 150 million CNY (20 million USD) Series C+ round
News
Technology
December 23, 2022
Correcting visual impairment: VGR-R01 project IND application accepted by Center for Drug Evaluation
News
Corporate
December 23, 2022
uBriGene Biosciences completes several hundred million yuan Series C round funding
News
Technology
April 21, 2022
Assisted Clinical Application of Gene Therapy for Hemophilia B of Vitalgen Accepted by NMPA
News
Technology
January 27, 2022
Assisted Clinical Application of Gene Therapy in Ophthalmology of Innostellar Accepted by NMPA
Event
Corporate
February 9, 2026 | San Diego, USA
uBriGene to Drive Innovation in Cell & Gene Therapy at Advanced Therapies Week 2026 in San Diego
Event
Corporate
January 12, 2026 | San Francisco, USA
Where Science Meets Strategy: uBriGene Engages Global Leaders at JPM Healthcare Conference 2026
Event
Corporate
December 6, 2025 | Orlando
uBriGene to Present High-Yield cGMP Lentiviral Vector Manufacturing Process at the 67th ASH Annual Meeting 2025
Event
Corporate
November 18, 2025 | Pennsylvania
Meet uBriGene in Philadelphia: Driving the Future of Cell and Gene Therapy at The Advanced Therapies Congress 2025
Event
Corporate
November 11, 2025 | Boston
uBriGene Biosciences to Showcase End-to-End TIL Manufacturing Innovation at the 7th TIL Therapies Summit in Boston, MA
Event
Corporate
September 23, 2025 | Boston
From LVV Turbo to CAR-TCR Solutions: uBriGene to Showcase Innovation at CAR-TCR Summit 2025 in Boston
Event
Corporate
June 11, 2025 | Hong Kong
uBriGene Heads to ISSCR 2025: Advancing iPSC Innovation on the Global Stage - Booth 907
Event
Corporate
June 10, 2025 | Boston, USA
Novel sgRNA In Vitro Transcription (IVT) Technology Enhances Gene Editing Efficiency to Debut at the 7th Annual Allogeneic Cell Therapies Summit
Event
Corporate
May 13, 2025 | New Orlean, LA, USA
Integrated CDMO Solutions & Scientific Excellence at ASGCT 2025 - Booth 2149
Event
Corporate
May 7, 2025 | New Orlean, LA, USA
uBriGene to Present Real Solutions in Cell & Gene Therapy at ISCT 2025 - Booth 705
Event
Corporate
April 22, 2025 | Washington, DC, USA
uBriGene to Showcase RNA-LNP CRDMO Expertise at the 25th World Vaccine Congress Washington
Event
Corporate
December 7, 2024 | San Diego, CA, USA
mRNA-LNP Mediated CAR-T Manufacturing from uBriGene Set to Shine at ASH 2024
Event
Corporate
November 12, 2024 | Boston, MA, USA
Breakthrough RNA Therapies From uBriGene Featured at the 12th International mRNA Health Conference
Event
Corporate
November 12, 2024 | Pennsylvania, PA, USA
Discover uBriGene’s Innovations at The Advanced Therapies Congress 2024!
Event
Corporate
October 27, 2024 | Rotterdam, Netherland
uBriGene Highlights Research at the 16th Oncolytic Virotherapy Conference, Rotterdam
Event
Corporate
October 7, 2024 | Phoenix, AZ, USA
Meet uBriGene at the Cell & Gene Meeting on the Mesa 2024
Event
Corporate
September 17, 2024 | Boston, MA, USA
Lunch & learn with uBriGene at the 9th CAR-TCR summit
Event
Corporate
June 3, 2024 | San Diego, CA, USA
Join uBriGene Biosciences to Discover the Future of Biotech at BIO San Diego Jun 03 - 06!
Event
Corporate
May 29, 2024 | Vancouver, BC, Canada
uBriGene's showcase at ISCT2024 Vancouver May 29 - Jun 1
Event
Corporate
May 7, 2024 | Baltimore, MD, USA
uBriGene will exhibit at ASGCT2024 this May 7 – 11 in Baltimore
